Sort
35,931 grants matching “parkinsons”
Molecular Mechanisms Controlling Formation of Basal Ganglia Circuitry
$578,834Kenneth J Campbell · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · MH
Molecular Mechanisms Controlling Formation of Basal Ganglia Circuitry
$578,834Kenneth J Campbell · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · MH
Molecular Mechanisms Controlling Formation of Basal Ganglia Circuitry
$578,804Kenneth J Campbell · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · MH
Mapping and function of odorant receptors in the human olfactory system
$578,672Thomas C Bozza · Northwestern University · R01 · FY2016 · DC
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers
$578,653David R Hessl · University Of California At Davis · R01 · FY2015 · MH
Parkinson Disease Clinical Subtypes: Validation, Clinical Utility, and Biological Correlates
$578,641Meghan C Campbell · Washington University · R01 · FY2024 · NS
Towards Therapeutics for Neurodegenerative Diseases
$578,495Stanley B Prusiner · University Of California, San Francisco · R37 · FY2012 · AG
Project IV: In Vivo Dissection of Genetic Modifiers on Different Stages of Synucleinopathy
$578,414Kelvin C Luk · University Of Pennsylvania · P01 · FY2025 · AG
Basal Ganglia Shape Analysis and Circuitry in Huntington's Disease
$578,379Michael I Miller · Johns Hopkins University · U01 · FY2012 · NS
Basal Ganglia Cortical Coupling and Connectivity Changes in PD and DBS
$578,337Jerrold L Vitek · University Of Minnesota · R01 · FY2014 · NS
Leveraging invasive recordings and immersive virtual reality to characterize freezing of gait mechanisms in Parkinson disease
$578,329Kathryn Amy Cross · University Of California Los Angeles · R01 · FY2025 · NS
Quality of Life for SCI Clinical Trials: Development of the SCI-QOL
$578,271David Scott Tulsky · Kessler Foundation, Inc. · R01 · FY2009 · HD
Rational derivation of DA neuron subtypes from iPS cells for improved modelling of Parkinson's disease
$578,201Dimitri Krainc · Northwestern University At Chicago · R01 · FY2019 · NS
Genetic analysis in families with neurological disease
$578,171Andrew Singleton · National Institute On Aging · ZIA · FY2011 · AG
Novel Systemic Delivery of Peptide-Mediated Anti-Sense Oligonucleotides for Dementia with Lewy Bodies
$578,101Robert A Rissman · University Of California, San Diego · R01 · FY2024 · AG
Retrograde Signaling by Endogenous Cannabinoids
$578,049Wade G Regehr · Harvard Medical School · R01 · FY2008 · DA
Efficacy of Voice Treatment for Parkinson's Disease
$578,031Lorraine O. Ramig · University Of Colorado · R01 · FY2008 · DC
Phase 1b Trial of stem cells in ALS
$577,888Jonathan David Glass · Emory University · R01 · FY2014 · NS
Miniature Passive Device for Locating Lost Dentures in Care Facilities
$577,884Suneel Ismail Sheikh · Aster Labs, Inc. · R44 · FY2020 · DE
Cortical correlates of gait in Parkinson's disease: impact of medication and cueing
$577,850Martina Mancini · Oregon Health & Science University · R01 · FY2023 · HD
Central Mechanisms of Airway Protection
$577,731Donald C Bolser · University Of Florida · R01 · FY2010 · HL
Viral Vector Transduction Deficiencies in the Aged Nigrostriatal System
$577,666Caryl E Sortwell · Michigan State University · R56 · FY2016 · AG
Mitochondria as crucial regulators of innate immune outcomes during Mycobacterium tuberculosis infection
$577,628Robert Owen Watson · Vanderbilt University Medical Center · R01 · FY2025 · AI
Preclinical development of a novel therapeutic for Parkinson's disease
$577,562Aarash Bordbar · Sinopia Biosciences, Inc. · R44 · FY2021 · NS
Mechanistic studies into regulation of the copper chaperone CCS by phosphorylation
$577,500Eva Ge · University Of North Carolina Charlotte · R15 · FY2025 · GM